Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/CL stock hub

CSE/CL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/CLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

525.2M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/CL

In the news

Latest news · CSE/CL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-45.8

P25 -121.5P50 -40.9P75 0.5

ROIC9.5

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/CL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	2,900
Employees Change	140%
Employees Change Percent	5.07
Enterprise value	CAD 1.2B
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA22587M1068
Last refreshed	2026-05-10
Market cap	CAD 525.2M
Price	CAD 1.42
Price currency	CAD
Rev Per Employee	308,732.95x
Sector	Healthcare
Sic	2834
Symbol	cse/CL
Website	https://www.crescolabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-35.63%
EV Earnings	-6.26x
EV/EBIT	11.23x
EV/EBITDA	5.56x
EV/FCF	-5,178.13x
EV/Sales	1.31x
FCF yield	-0.04%
P/B ratio	1.54x
P/S ratio	0.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.65%
EBITDA Margin	19.13%
Gross margin	50.11%
Gross Profit	CAD 448.6M
Gross Profit Growth	-9.08%
Gross Profit Growth Q	-0.9%
Gross Profit Growth3 Y	-4.96%
Gross Profit Growth5 Y	3.55%
Net Income	CAD -187.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-15.17%
Profit Margin	-20.9%
Profit Per Employee	CAD -64,521
ROA	3.64
Roa5y	3.76
ROCE	6.79
ROE	-45.77
Roe5y	-33.67
ROIC	9.47
Roic5y	8.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.38%
Cagr3y	-14.09%
Cagr5y	-38.27%
EPS Growth Quarters	1
EPS Growth Years	0
OCF Growth	-70.91%
OCF Growth3 Y	13.11%
OCF Growth5 Y	-3.19%
Revenue Growth	-9.46x
Revenue Growth Q	-7.31x
Revenue Growth Years	0x
Revenue Growth3 Y	-7.33x
Revenue Growth5 Y	2.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.5
Assets	CAD 1.7B
Cash	CAD 45.1M
Current Assets	CAD 337.2M
Current Liabilities	CAD 134.2M
Debt	CAD 819.1M
Debt EBITDA	CAD 3.89
Debt Equity	CAD 2.4
Debt FCF	CAD -3,622
Equity	CAD 340.9M
Interest Coverage	1.24
Liabilities	CAD 1.3B
Long Term Assets	CAD 1.3B
Long Term Liabilities	CAD 1.2B
Net Cash	CAD -773.9M
Net Cash By Market Cap	CAD -147
Net Debt EBITDA	CAD 4.52
Net Debt Equity	CAD 2.27
Tangible Book Value	CAD -225.4M
Tangible Book Value Per Share	CAD -0.62
WACC	10.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.51
Inventory Turnover	3.28
Net Working Capital	CAD 195.4M
Quick ratio	0.72
Working Capital	CAD 207.3M
Working Capital Turnover	CAD 5.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.37%
200-day SMA	1.47
3Y total return	-36.61%
50-day SMA	1.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.04%
All Time High	22.2
All Time High Change	-93.6%
All Time High Date	2021-02-10
All Time Low	0.6
All Time Low Change	136.67%
All Time Low Date	2025-06-23
ATR	0.14
Beta	1.7
Beta1y	1.46
Beta2y	2.12
Ch YTD	-14.46
High	1.49
High52	3.12
High52 Date	2025-12-18
High52ch	-54.49%
Low	1.37
Low52	0.6
Low52 Date	2025-06-23
Low52ch	136.67%
Ma50ch	5.81%
Price vs 200-day SMA	-3.53%
RSI	50.73
RSI Monthly	45.37
RSI Weekly	50.65
Sharpe ratio	0.78x
Sortino ratio	1.51
Total Return	-3.13%
Tr YTD	-14.46
Tr1m	14.52%
Tr1w	-4.7%
Tr3m	-0.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 104.3M
Operating Income Growth	-20.57
Operating Income Growth Q	-17.78
Operating Income Growth3 Y	16.27
Operating Income Growth5 Y	24.9
Operating margin	11.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	308,575,118%
Net Borrowing	-82,356,560.2
Shares Insiders	12.48%
Shares Institutions	20.27%
Shares Out	369,839,200
Shares Qo Q	1.2%
Shares Yo Y	3.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -19.4M
Average Volume	289,678x
Bv Per Share	1.29
CAPEX	CAD -51.6M
Ch1m	14.52
Ch1w	-4.7
Ch1y	21.37
Ch3m	-0.7
Ch3y	-36.61
Ch5y	-91.04
Ch6m	-6.58
Change	-5.33%
Change From Open	-4.7
Close	1.5
Days Gap	-0.67
Depreciation Amortization	65,647,108.1
Dollar Volume	459,237.9
Earnings Date	2026-05-08
EBIT	CAD 104.3M
EBITDA	CAD 171.3M
EPS	CAD -0.53
F Score	4
FCF	CAD -226,129
FCF EV Yield	-0.02x
FCF Per Share	CAD -0
Financing CF	-118,649,496
Fiscal Year End	December
Founded	1,990
Goodwill	285,769,499.1
Income Tax	CAD 62.2M
Investing CF	-65,698,943
Is Primary Listing	1
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Ma150	1.48
Ma150ch	-4.12%
Ma20	1.41
Ma20ch	1%
Net CF	-133,015,687
Next Earnings Date	2026-08-05
Open	1.49
P OCF Ratio	10.22
Position In Range	41.67
Ppne	583,968,216.7
Price Date	2026-05-08
Price EBITDA	CAD 3.07
Relative Volume	1.16x
Revenue	895,325,542x
SBC By Revenue	2.15x
Share Based Comp	19,214,013
Tax By Revenue	6.94x
Tr6m	-6.58%
Volume	323,407

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/CL pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/CL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/CL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.3%

Share of float held by funds and institutions

Insider ownership

+12.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.1%

Negative means the company is buying back shares.

Technical

CSE/CL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.7

Neutral momentum band

Price vs 200-day MA

-3.5%

50/200-day relationship not available

Beta (5Y)

1.70

More volatile than the market

Sharpe ratio

0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/CL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/CL stock rating?

cse/CL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/CL analysis?

The full report lives at /stocks/cse/CL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/CL?

The latest report frames cse/CL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/CL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.